Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
CB Financial Services | CBFV | Jul 26, 2024 | 25.00 | 0.00 |
CBAK Energy Technology | CBAT | Jul 26, 2024 | 1.39 | +10.32 |
CbdMD | YCBD | Jul 26, 2024 | 0.58 | -3.53 |
cbdMD Pref A | YCBD-A | Jul 26, 2024 | 0.45 | 0.00 |
CBIZ | CBZ | Jul 26, 2024 | 85.66 | +2.53 |
CBL International | BANL | Jul 26, 2024 | 0.94 | -1.05 |
CBOE Holdings | CBOE | Jul 26, 2024 | 186.46 | -0.32 |
Cbre Global Real Estate Income Fund | IGR | Jul 26, 2024 | 5.59 | +0.36 |
CBRE Group | CBRE | Jul 26, 2024 | 110.55 | +2.90 |
CCC Intelligent Solutions | CCCS | Jul 26, 2024 | 11.10 | +0.82 |
Ccsc Technology International | CCTG | Jul 26, 2024 | 1.65 | -10.81 |
CDT Environmental Technology Investment Holdings | CDTG | Jul 26, 2024 | 3.00 | 0.00 |
CDW | CDW | Jul 26, 2024 | 229.74 | +0.49 |
CEA Industries | CEAD | Jul 26, 2024 | 6.71 | 0.00 |
Cedar Realty Trust B Pref | CDR-B | Jul 26, 2024 | 13.61 | +0.22 |
Cedar Realty Trust C Pref | CDR-C | Jul 26, 2024 | 12.37 | -1.67 |
CEF Income Composite Powershares | PCEF | Jul 26, 2024 | 18.82 | +0.32 |
Cel-Sci | CVM | Jul 26, 2024 | 1.31 | +8.26 |
Celanese | CE | Jul 26, 2024 | 139.08 | +1.59 |
Celcuity | CELC | Jul 26, 2024 | 18.73 | -2.19 |
Celestica | CLS | Jul 26, 2024 | 52.67 | +3.13 |
Celldex Therapeutics | CLDX | Jul 26, 2024 | 44.56 | +1.60 |
Cellebrite | CLBT | Jul 26, 2024 | 13.98 | +2.01 |
Cellectar Biosciences | CLRB | Jul 26, 2024 | 2.29 | -3.17 |
Cellectis ADR | CLLS | Jul 26, 2024 | 2.30 | +12.20 |
Celsius | CELH | Jul 26, 2024 | 48.02 | +3.50 |
Celularity A | CELU | Jul 26, 2024 | 3.14 | +5.02 |
Cementos Pacasmayo ADR | CPAC | Jul 26, 2024 | 5.73 | +4.95 |
CEMEX ADR | CX | Jul 26, 2024 | 6.42 | +0.78 |
Cemtrex | CETX | Jul 26, 2024 | 0.20 | -0.83 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.